On April 18, 2016, Green Leaf Medical Group announced that it has officially completed a $688 million delivery with Healthe Care, Australia's third largest private hospital group. Since then, Healthe Care has officially belonged to Green Leaf Healthcare.
Through this transaction, Green Leaf Medical successfully entered the ranks of China's largest international comprehensive private medical group from the pharmaceutical field. Healthe Care will also officially enter the Chinese market, and work with Green Leaf Healthcare to build a high-end hospital group that meets the needs of the Chinese market and targets high-end and high-end people.
Affected by the aging of the population and industrial policies, the Chinese medical service market has entered a period of rapid release. The data shows that the Chinese hospital market has an industry scale of about 280 billion US dollars. The compound income growth rate of hospitals in 2009-2013 is 20%, and the annual growth rate of private hospital systems is as high as 28%. However, due to the lack of policy support and industrial structural problems, it is difficult for private hospitals to achieve specialization, high-end, and branding. As a result, the number of patients admitted to China's private medical system is only 10% of the total, which is significantly lower than the 20% set by the government. ~30% of the goal.
It is reported that Healthe Care was established in 2005 and has 17 medical institutions in major cities and regions of Australia. It has nearly 2,000 beds, more than 50 operating rooms and 4,500 employees, and annual sales of about 3 billion yuan. Healthe Care's strengths are in the areas of cancer, heart, cranial nerves, orthopedics, rehabilitation, maternity and general medical services, with state-of-the-art medical technology and equipment. Healthe Care is the first in the world to build a hybrid operating room and is the first medical facility in Australia to introduce a spinal robot. Its day surgery center is equipped with a more detailed pre-operative evaluation process, more advanced operating room conditions and equipment, more professional and experienced surgeons and anesthesiologists, a more scientific medical procedure and a better post-operative follow-up system. It has also become a distinctive advantage service of Healthe Care.
Founded in 1994, Green Leaf Group is an innovative company dedicated to the development of the health industry. Its Green Leaf Pharmaceutical Group is a professional pharmaceutical group driven by R&D. It was listed on the Main Board of Hong Kong in 2014. The business focuses on product development, production and sales in the areas of anti-tumor, cardiovascular, diabetes and central nervous system. Now it has become China's leading innovative pharmaceutical company, reaching the international advanced level in the innovation of new formulation technology. In the field of central nervous and spiritual, there have been many innovative products of microsphere preparations registered clinical research in the US FDA, and achieved breakthroughs. Progress is expected to be the first Chinese pharmaceutical company to list new drugs in the United States.
“The addition of Healthe Care is an important milestone in the history of green leaf medical development. It has great strategic and far-reaching impact on the development of medical business, and has established the leading position of Green Leaf Medical and Green Leaf Group in the world, especially in China.†Mr. Liu Dianbo, Chairman of Green Leaf Group It is said that Healthe Care's focus and expertise in areas such as cancer, heart, cranial nerves, orthopedics, rehabilitation, etc. are consistent with the key specialists for green leaf medical treatment; it also coincides with the key therapeutic areas of the Group's Green Leaf Pharmaceutical Group products.
Steve Atkins, CEO of Healthe Care, said that Green Leaf Medical Group chose Healthe Care to recognize the company's consistently high quality medical services. “In the process of understanding and communication with the management of Green Leaf Medical Group, I was deeply impressed by the vision and sincere commitment of Green Leaf Group. I firmly believe that Green Leaf Healthcare will continue to support Healthe Care's business development in the future; I look forward to the management of Green Leaf Medical Group. Collaborate and learn from each other in the medical profession; we hope that our doctors and staff will work hand in hand with Green Leaf Medical Partners to provide the highest level of medical care for Australia and China and the world's more patients."
It is reported that Green Leaf Medical Group has started to lay out the medical market five years ago and has been paying attention to the active private medical market. In 2015, the High-end Brain Disease Rehabilitation Hospital of Shandong Province, jointly established by Green Leaf Medical Group and South Korea's Bob Bas Memorial Hospital, is located in Shandong International Biotechnology Park, High-tech Zone, Yantai City. It is provided by the Korean Bobs Medical Foundation and Shuyou Group. Technical management such as education and training, with the main business of diagnosis and treatment of cranial nerve diseases and chronic medical diseases, is committed to improving the level of medical technology in the field of brain rehabilitation.
According to Green Leaf Medical, the first two hospitals in the cooperation will be located in Chongqing and Shanghai respectively, and plans to operate 10 hospitals in China by 2020, with oncology, heart, cranial nerves, orthopedics, and The interoperative center is the main medical treatment project.
Liu Dianbo said: This international acquisition is extremely important for the development and growth of the new business of Green Leaf Medical Group. Will vigorously promote the development of green leaf medical care in the Chinese market. Drawing on and introducing international advanced medical technology, operation mode and management system, Green Leaf Medical will bring high standards and international medical service experience to the people, and will also meet people's higher demand for medical health, improve people's livelihood and promote society. Make more contributions to overall development.
It is understood that this acquisition is very likely to be the largest overseas medical business merger of China's private medical group, and also the largest medical investment project of Chinese companies in Australia.
This pleated Skirt is made of blue and white checked synthetic fabric, having a three-dimensional silhouette to flatter the body. Skirt pleats, as elegant as organ pleats, reflect your charm.It is suitable for your daily wear, comfortable and beautiful.The factory has excellent garment production technology, a professional team and many years of garment manufacturing experience. The main product categories include beach pants, T-shirts, windbreakers, sweaters, Casual Pants, etc. Clothing, casual pants, etc.
Chemical Fiber Skirt,Women Skirts,Mid Length Skirts,Women Chemical Fiber Skirt
Xinhui Jielide Garment Factory , https://www.ntgfwear.com